• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Video

Burden and QoL Impacts on GPP

Author(s):

Michael Payette, MD, MBA, FAAD

Dr Michael Payette discusses the patient QoL impacts and burden of generalized pustular psoriasis.

Related Videos
4 KOLs are featured on this panel.
4 KOLs are featured on this panel.
4 KOLs are featured on this panel.
4 KOLs are featured on this panel.
Omar Noor, MD, FAAD, is featured in this series.
Omar Noor, MD, FAAD, is featured in this series.
Omar Noor, MD, FAAD, is featured in this series.
Omar Noor, MD, FAAD, is featured in this series.
4 KOLs are featured on this panel.
4 KOLs are featured on this panel.
Related Content
Fighting the Flare of GPP: Expert Insights on Spesolimab
December 18th 2024

Fighting the Flare of GPP: Expert Insights on Spesolimab

The Cutaneous Connection: An Inside Look of the Inclusive Atlas
November 4th 2021

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

2024 Key Insights: Psoriasis
December 13th 2024

2024 Key Insights: Psoriasis

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
September 23rd 2021

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

Deucravacitinib Improves Psoriasis Symptoms in Japanese Patients
December 11th 2024

Deucravacitinib Improves Psoriasis Symptoms in Japanese Patients

Psoriasis Patients Without Insurance Are More Likely Unable to Obtain Care
December 10th 2024

Psoriasis Patients Without Insurance Are More Likely Unable to Obtain Care

© 2024 MJH Life Sciences

All rights reserved.